MapLight Therapeutics, Inc. ( MPLT) - Key Metrics
MPLT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.32 | -$0.99 | -$0.99 |
| 2026Q1 | $0 | -$1.34 | -$1.13 | -$1.13 |
| 2025Q4 | $0 | -$1.81 | -$1.06 | -$1.07 |
| 2025Q3 | $0 | -$0.71 | -$0.77 | -$0.77 |
| 2025Q2 | $0 | -$0.72 | -$0.82 | -$0.82 |
MPLT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.79 |
| 2026Q1 | 0% | -3.79 |
| 2025Q4 | 0% | -2.43 |
| 2025Q3 | 0% | -6.46 |
| 2025Q2 | 0% | -6.37 |
MPLT
Price: $11.23
52 week price:
Earnings Per Share: -20.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 548.2 million